» Articles » PMID: 19542279

Proteomic and Genomic Characterization of Highly Infectious Clostridium Difficile 630 Spores

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2009 Jun 23
PMID 19542279
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium difficile, a major cause of antibiotic-associated diarrhea, produces highly resistant spores that contaminate hospital environments and facilitate efficient disease transmission. We purified C. difficile spores using a novel method and show that they exhibit significant resistance to harsh physical or chemical treatments and are also highly infectious, with <7 environmental spores per cm(2) reproducibly establishing a persistent infection in exposed mice. Mass spectrometric analysis identified approximately 336 spore-associated polypeptides, with a significant proportion linked to translation, sporulation/germination, and protein stabilization/degradation. In addition, proteins from several distinct metabolic pathways associated with energy production were identified. Comparison of the C. difficile spore proteome to those of other clostridial species defined 88 proteins as the clostridial spore "core" and 29 proteins as C. difficile spore specific, including proteins that could contribute to spore-host interactions. Thus, our results provide the first molecular definition of C. difficile spores, opening up new opportunities for the development of diagnostic and therapeutic approaches.

Citing Articles

An Investigation into the Prevalence of in Irish Pig Abattoirs and Pork Meat Products as a Potential Source of Human Infection.

Doyle A, Rogers T, Bolton D, Burgess C, Whyte P, Frias J Antibiotics (Basel). 2025; 14(2).

PMID: 40001395 PMC: 11852017. DOI: 10.3390/antibiotics14020151.


Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against Infection.

Wang S, Heuler J, Bullock J, Qin J, Chakraborty S, Nathaniel A Vaccines (Basel). 2025; 13(1).

PMID: 39852800 PMC: 11768939. DOI: 10.3390/vaccines13010021.


Spores of Clostridioides difficile are toxin delivery vehicles.

Cassona C, Ramalhete S, Amara K, Candela T, Kansau I, Deneve-Larrazet C Commun Biol. 2024; 7(1):839.

PMID: 38987278 PMC: 11237016. DOI: 10.1038/s42003-024-06521-x.


Reviewing the Mouse Model: Insights into Infection Mechanisms.

Fachi J, Vinolo M, Colonna M Microorganisms. 2024; 12(2).

PMID: 38399676 PMC: 10891951. DOI: 10.3390/microorganisms12020273.


The multiplicity of thioredoxin systems meets the specific lifestyles of Clostridia.

Anjou C, Lotoux A, Zhukova A, Royer M, Caulat L, Capuzzo E PLoS Pathog. 2024; 20(2):e1012001.

PMID: 38330058 PMC: 10880999. DOI: 10.1371/journal.ppat.1012001.


References
1.
Farrow K, Lyras D, Rood J . The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes. Antimicrob Agents Chemother. 2000; 44(2):411-3. PMC: 89693. DOI: 10.1128/AAC.44.2.411-413.2000. View

2.
Setlow P . Deoxyribonucleic acid synthesis and deoxynucleotide metabolism during bacterial spore germination. J Bacteriol. 1973; 114(3):1099-107. PMC: 285370. DOI: 10.1128/jb.114.3.1099-1107.1973. View

3.
Rupnik M . Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?. Clin Microbiol Infect. 2007; 13(5):457-9. DOI: 10.1111/j.1469-0691.2007.01687.x. View

4.
Kim J, Darley D, Buckel W, Pierik A . An allylic ketyl radical intermediate in clostridial amino-acid fermentation. Nature. 2008; 452(7184):239-42. DOI: 10.1038/nature06637. View

5.
Fagan R, Albesa-Jove D, Qazi O, Svergun D, Brown K, Fairweather N . Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol. 2009; 71(5):1308-22. DOI: 10.1111/j.1365-2958.2009.06603.x. View